300 related articles for article (PubMed ID: 25652561)
1. Drug makers' adverse event reports are often incomplete, US report finds.
McCarthy M
BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
[No Abstract] [Full Text] [Related]
2. Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database.
Meier L; Wang EY; Tomes M; Redberg RF
JAMA Intern Med; 2020 Jan; 180(1):147-148. PubMed ID: 31589249
[TBL] [Abstract][Full Text] [Related]
3. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.
Li AS; Pomeranz HD
J Neuroophthalmol; 2016 Dec; 36(4):480-481. PubMed ID: 27851718
[No Abstract] [Full Text] [Related]
4. Evaluating the completeness and accuracy of MedWatch data.
Getz KA; Stergiopoulos S; Kaitin KI
Am J Ther; 2014; 21(6):442-6. PubMed ID: 23011177
[TBL] [Abstract][Full Text] [Related]
5. Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis.
Araujo AGS; Lucchetta RC; Tonin FS; Pontarolo R; Borba HHL; Wiens A
Expert Opin Drug Saf; 2021 Jun; 20(6):735-740. PubMed ID: 33641547
[No Abstract] [Full Text] [Related]
6. Outliers and patients with adverse drug reactions.
Edwards IR
Drug Saf; 2009; 32(8):623-4. PubMed ID: 19591527
[No Abstract] [Full Text] [Related]
7. US Food and Drug Administration: adverse event reporting.
Graham AA
CRNA; 1998 Nov; 9(4):135-8. PubMed ID: 9866488
[TBL] [Abstract][Full Text] [Related]
8. Use of Live Attenuated Influenza Vaccine in Children With Egg Allergy and Asthma.
Kelso JM
J Pediatric Infect Dis Soc; 2015 Mar; 4(1):81-2. PubMed ID: 26407364
[No Abstract] [Full Text] [Related]
9. Adverse drug events and near misses: who's counting?
Wu AW
Am J Med; 2000 Aug; 109(2):166-8. PubMed ID: 10967161
[No Abstract] [Full Text] [Related]
10. Postmarketing modifications in the safety labeling of the new antiepileptics.
Buck ML; Gurka MJ; Goodkin HP
Neurology; 2007 May; 68(18):1536-7. PubMed ID: 17470758
[No Abstract] [Full Text] [Related]
11. Adverse drug and device reactions in the oral cavity: surveillance and reporting.
Zavras AI; Rosenberg GE; Danielson JD; Cartsos VM
J Am Dent Assoc; 2013 Sep; 144(9):1014-21. PubMed ID: 23989840
[TBL] [Abstract][Full Text] [Related]
12. [Safety of medicinal products and reporting of adverse drug reactions].
Skibicka I; Maciejczyk A
Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
[TBL] [Abstract][Full Text] [Related]
13. The role of databases in drug postmarketing surveillance.
Rodriguez EM; Staffa JA; Graham DJ
Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
[TBL] [Abstract][Full Text] [Related]
14. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
15. Drugs associated with adverse events in children and adolescents.
Lee WJ; Lee TA; Pickard AS; Caskey RN; Schumock GT
Pharmacotherapy; 2014 Sep; 34(9):918-26. PubMed ID: 24990656
[TBL] [Abstract][Full Text] [Related]
16. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
18. Statistics: detecting a rare adverse drug reaction using spontaneous reports.
Schroeder DR
Reg Anesth Pain Med; 1998; 23(6 Suppl 2):183-9. PubMed ID: 9845392
[No Abstract] [Full Text] [Related]
19. A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes.
Hoffman KB; Dimbil M; Kyle RF; Tatonetti NP; Erdman CB; Demakas A; Chen D; Overstreet BM
J Manag Care Spec Pharm; 2015 Dec; 21(12):1134-43. PubMed ID: 26679963
[TBL] [Abstract][Full Text] [Related]
20. European pharmacovigilance: an overview of pharmacovigilance inspections.
Koster MC; van den Oetelaar AH
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):711-3. PubMed ID: 16142691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
